Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

56.23 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,122
Open 56.23
Bid (Size) 56.56 (2)
Ask (Size) 56.75 (1)
Prev. Close 56.23
Today's Range 56.23 - 56.23
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease. 
Via Investor's Business Daily

Performance

YTD
+207.60%
+207.60%
1 Month
-28.10%
-28.10%
3 Month
-36.03%
-36.03%
6 Month
+223.91%
+223.91%
1 Year
+150.36%
+150.36%

More News

Read More
What's Going On With Viking Therapeutics Stock On Tuesday?
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
Via Benzinga
Market Whales and Their Recent Bets on VKTX Options
Via Benzinga
Where Will Viking Therapeutics Be in 5 Years?
Via The Motley Fool
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
Via The Motley Fool
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Via The Motley Fool
Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing
Via InvestorPlace
3 Underappreciated Stocks with Triple-Digit Upside: May 2024
Via InvestorPlace
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Via InvestorPlace
Exposures Product Safety
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
Via InvestorPlace
2 Stocks That Could 10x by 2035
Via The Motley Fool
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
Via InvestorPlace
Is It Too Late to Buy Viking Therapeutics Stock?
Via The Motley Fool
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Via Benzinga
Topics ETFs
3 Growth Stocks That Could Be Millionaire-Makers: May Edition
Via InvestorPlace
Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
3 Monster Stocks in the Making You Can Buy Right Now
Via The Motley Fool
Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?
Via InvestorPlace
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.